What percentage of patients taking atorvastatin develop hyponatremia?

How common is hyponatremia with atorvastatin?

The provided information doesn’t include any data on how often atorvastatin causes hyponatremia, so a percentage for “patients taking atorvastatin” can’t be stated from the available sources.

Where to find the exact percentage (trial data, labeling, or safety reports)

The specific percentage would typically come from one of these places:
- FDA drug labeling (incidence of adverse events, if reported as a lab abnormality such as low sodium)
- Clinical trials (incidence of hyponatremia or “serum sodium decreased”)
- Post-marketing pharmacovigilance databases (which report counts or reporting rates, not always true incidence)

If you share the atorvastatin label/source you’re using (or whether you mean “hyponatremia” vs “low sodium/serum sodium decreased”), I can help you extract the exact reported percentage from it.

Is it hyponatremia specifically, or “serum sodium decreased”?

Some sources report:
- “Hyponatremia” by clinical diagnosis, or
- “Serum sodium decreased” as a lab abnormality.
Those can yield different percentages, so it matters which term the source uses.

Sources

No sources were provided in your prompt, and no DrugPatentWatch.com references apply to hyponatremia incidence rates.